EMEA-002215-PIP01-17-M03
Key facts
| Active substance |
|
| Therapeutic area |
Vaccines
|
| Decision number |
P/0244/2019
|
| PIP number |
EMEA-002215-PIP01-17-M03
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Prevention of disease caused by Streptococcus pneumoniae
|
| Route(s) of administration |
Intramuscular use
|
| Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
E-mail: pip.information@merck.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-002215-PIP01-17-M03
|
| Compliance opinion date |
17/12/2021
|
| Compliance outcome |
positive
|